Publication | Open Access
NR1D1 Stimulates Antitumor Immune Responses in Breast Cancer by Activating cGAS-STING Signaling
38
Citations
35
References
2023
Year
NR1D1 suppresses breast cancer progression and lung metastasis by enhancing antitumor immunity via cGAS-STING pathway activation, which provides potential immunotherapeutic strategies for breast cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1